ArticleScientific reports2025
The effects of 3-hydroxyflavone complexes with transition metal ions on the physicochemical and microbial properties of bacterial cell membranes.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Synthesis, characterisation and antibacterial activity of flavone-based Sn(iv) and Sb(iii) complexes.RSC advances · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Flavonoids are natural antibacterial agents, and their bioavailability can be improved by metal complexation. This study examines 3-hydroxyflavone complexes with Co(II), Mn(II), and Zn(II) against Staphylococcus aureus and Escherichia coli. Antibacterial activity and membrane permeability were tested in vitro, while Langmuir monolayers modeled physicochemical interactions with bacterial membranes and their major lipid components. The results demonstrated that, particularly at the highest tested molar ratio, the metal complexes of 3HF exhibited greater antibacterial efficacy than the 3HF independently. Escherichia coli demonstrated greater sensitivity to the tested compounds, than S. aureus. The tested 3HF-complexes were identified as bacteriostatic. In E. coli, both physicochemical and microbiological changes were observed following treatment with Co(II)-3HF and Zn(II)-3HF complexes. In contrast, the Mn(II)-3HF complex affected only model membrane properties without notable microbiological effects. For S. aureus, only the zinc(II) complex showed effective microbiological action on the native cell and activity on the inner membrane (in the model studies), with efficacy ranked as follows: Mn(II)-3HF ≥ Co(II-3HF) > Zn(II)-3HF. Increased permeability of E. coli and S. aureus membranes (in vitro assays) has been proposed as a mechanism for the antibacterial action of the Co(II)-3HF and Zn(II)-3HF complexes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.